[go: up one dir, main page]

FR2811226A1 - Cosmetic composition for treatment of aging or dehydrated skin contains vegetable protein having trypsin inhibiting activity or vegetable extract rich in such protein - Google Patents

Cosmetic composition for treatment of aging or dehydrated skin contains vegetable protein having trypsin inhibiting activity or vegetable extract rich in such protein Download PDF

Info

Publication number
FR2811226A1
FR2811226A1 FR0007156A FR0007156A FR2811226A1 FR 2811226 A1 FR2811226 A1 FR 2811226A1 FR 0007156 A FR0007156 A FR 0007156A FR 0007156 A FR0007156 A FR 0007156A FR 2811226 A1 FR2811226 A1 FR 2811226A1
Authority
FR
France
Prior art keywords
protein
extract
plant
trypsin
cosmetic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR0007156A
Other languages
French (fr)
Other versions
FR2811226B1 (en
Inventor
Olivier Courtin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Clarins SAS
Original Assignee
Laboratoires Clarins SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Clarins SAS filed Critical Laboratoires Clarins SAS
Priority to FR0007156A priority Critical patent/FR2811226B1/en
Publication of FR2811226A1 publication Critical patent/FR2811226A1/en
Application granted granted Critical
Publication of FR2811226B1 publication Critical patent/FR2811226B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645Proteins of vegetable origin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9767Pinaceae [Pine family], e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

Cosmetic composition for skin treatment, containing vegetable protein or vegetable extract with trypsin-inhibiting activity, is new. Independent claims are also included for: (1) use of vegetable trypsin inhibitor or plant extract containing such inhibitor as active agent for protection or regeneration of skin collagen; and (2) a process of cosmetic treatment of aging or dehydrated skin comprising topical application of sufficient quantity of vegetable trypsin inhibitor or plant extract containing such inhibitor.

Description

COMPOSITION COSMETIQUE HYDRATANTE COMPRENANT UNMOISTURIZING COSMETIC COMPOSITION COMPRISING A

INHIBITEUR DE TRYPSINE VÉGÉTAL.PLANT TRYPSIN INHIBITOR.

La présente invention concerne des compositions cosmétiques, éventuellement dermatologiques, pour le soin de la peau, notamment pour lutter contre le vieillissement ou pour hydrater la peau à base d'extrait de plante. Plus particulièrement, les compositions de l'invention sont basées sur la compréhension du rôle du collagène cutané notamment du fait de son aptitude à fixer de l'eau et de  The present invention relates to cosmetic compositions, possibly dermatological, for skin care, in particular for combating aging or for moisturizing the skin based on plant extract. More particularly, the compositions of the invention are based on an understanding of the role of skin collagen, in particular because of its ability to fix water and

l'impact de sa dégradation au cours du vieillissement (C.  the impact of its degradation during aging (C.

Durandeau et al., S.T.P. Pharma 5(89), 541-547, 1989). Il a ainsi été proposé dans l'art antérieur de nombreuses préparations cosmétiques à base de collagène pour leur  Durandeau et al., S.T.P. Pharma 5 (89), 541-547, 1989). Numerous cosmetic preparations based on collagen have thus been proposed in the prior art for their

pouvoir hydratant.hydrating power.

La Demanderesse s'est maintenant intéressée au phénomène de destruction de fibres cutanées par les protéases et plus particulièrement du collagène de la peau  The Applicant is now interested in the phenomenon of destruction of skin fibers by proteases and more particularly skin collagen

par les collagénases (L. Robert et A.M Robert, J. Med. Est.  by collagenases (L. Robert and A.M Robert, J. Med. Est.

Et Chir. Derm., Vol. XX, 80, Décembre 93, 211-217). Or, la maturation cutanée des collagénases nécessite l'intervention d'une autre enzyme protéolytique qui est la trypsine. En effet, cette protéase joue un rôle particulier au niveau de la peau o les fibroblastes synthétisent de nombreuses enzymes, la collagénase dont on connaît la fonction essentielle dans le renouvellement de la matrice extracellulaire et le vieillissement de la peau. Comme beaucoup d'enzymes, elle est élaborée sous une forme de pro-collagénase inactive qui est clivée par la trypsine  And Chir. Derm., Vol. XX, 80, December 93, 211-217). However, the cutaneous maturation of collagenases requires the intervention of another proteolytic enzyme which is trypsin. Indeed, this protease plays a particular role in the skin where fibroblasts synthesize many enzymes, collagenase, whose essential function is known in the renewal of the extracellular matrix and the aging of the skin. Like many enzymes, it is produced in the form of an inactive pro-collagenase which is cleaved by trypsin

pour être active.to be active.

La présente invention a donc pour objet une composition cosmétique pour la peau caractérisée en ce qu'elle comprend une protéine végétale ou un extrait  The present invention therefore relates to a cosmetic composition for the skin, characterized in that it comprises a vegetable protein or an extract

végétal présentant une activité inhibitrice de la trypsine.  plant with trypsin inhibiting activity.

L'invention envisage bien entendu une protéine végétale cosmétiquement acceptable et de préférence un extrait végétal riche en une telle protéine. Une composition cosmétique selon l'invention est donc remarquable en ce qu'elle permet de contrôler l'activité collagénasique dans les tissus en abaissant le taux de trypsine ou en l'inhibant de façon à bloquer la cascade de l'activation des protéases de matrice  The invention naturally envisages a cosmetically acceptable vegetable protein and preferably a vegetable extract rich in such a protein. A cosmetic composition according to the invention is therefore remarkable in that it makes it possible to control the collagenase activity in the tissues by lowering the level of trypsin or by inhibiting it so as to block the cascade of activation of the matrix proteases

extracellulaire et ainsi régénérer le collagène de la peau.  extracellular and thus regenerate the collagen in the skin.

L'invention offre ainsi de nouveaux procédés de traitement cosmétique du vieillissement ou de la déshydratation de la peau par application topique chez un sujet d'une quantité efficace d'un inhibiteur de trypsine végétal ou d'un extrait de plante contenant un tel  The invention thus provides novel methods of cosmetic treatment of aging or dehydration of the skin by topical application to a subject of an effective amount of a plant trypsin inhibitor or a plant extract containing such a

inhibiteur, et tout particulièrement ceux décrits ci-après.  inhibitor, and especially those described below.

La Demanderesse s'est intéressée tout particulièrement à une classe d'inhibiteurs de protéase, désignés inhibiteurs de Bowman-Birk. Ces inhibiteurs ont  The Applicant is particularly interested in a class of protease inhibitors, designated Bowman-Birk inhibitors. These inhibitors have

déjà été décrits comme présentant des activités anti-  previously described as exhibiting anti

élastasique, anti-inflammatoire. Les inhibiteurs de cette classe présentent en outre deux sites actifs capables d'inhiber chacun une protéase. Ainsi en présence d'inhibiteur Bowman-Birk, la trypsine et la chymotrypsine perdent leur activité lytique. L'invention a donc pour objet l'utilisation d'un inhibiteur de trypsine végétal, notamment un inhibiteur de type Bowman-Birk ou d'un extrait végétal riche en l'un de ces inhibiteurs comme agent actif dans la protection ou la régénération du collagène de la peau et donc utile pour la préparation d'une composition  elastic, anti-inflammatory. Inhibitors of this class also have two active sites capable of each inhibiting a protease. Thus in the presence of Bowman-Birk inhibitor, trypsin and chymotrypsin lose their lytic activity. The subject of the invention is therefore the use of a plant trypsin inhibitor, in particular a Bowman-Birk type inhibitor or a plant extract rich in one of these inhibitors as active agent in the protection or regeneration of the skin collagen and therefore useful for the preparation of a composition

cosmétique, notamment anti-vieillissement ou hydratatante.  cosmetic, in particular anti-aging or moisturizing.

Parmi les inhibiteurs de Bowman-Birk, l'invention vise spécifiquement une protéine végétale dénommée la prohibine dont la présence a été décrite chez plusieurs légumineuses comme le soja, le pois et la féverole, toute partageant une grande homologie de séquence. L'invention s'intéresse tout préférentiellement à la prohibine de Phaseolus lunatus dont le nom commun est Lima bean. Phaseolus lunatus est répandue en Amérique Centrale et en Amérique du Sud. Il s'agit d'une plante buissonnante atteignant 50 cm à maturité et produisant des gousses dont on tire les fèves accommodables dans diverses préparations culinaires. La fève est riche en protéine (21%) , en carbohydrates (63%) et en sels minéraux (2,4%) mais ne contient que très peu de lipides (0,6%). La prohibine est une protéine synthétisée par la plante probablement en tant que système stabilisateur de la graine en attente de la germination ou bien est utilisée comme défense contre les attaques d'insectes qui produisent des protéinases. La présente invention se rapporte donc tout spécialement à une composition cosmétique comprenant une protéine végétale inhibant la trypsine appartenant à la classe des inhibiteurs de Bowman-Birk ou un extrait végétal riche en cette protéine. Avantageusement, l'invention concerne une composition comprenant un extrait de légumineuse comme le soja, le pois, la féverole, ou de façon toute préférée, de Phaseolus lunatus. Il s'agit d'un extrait protéique ou d'un extrait riche en protéine présentant une activité inhibitrice de trypsine qui peuvent être obtenus par extraction et isolement, voire purification plus ou moins poussée, selon des techniques  Among the Bowman-Birk inhibitors, the invention specifically targets a plant protein called prohibin, the presence of which has been described in several legumes such as soybeans, peas and faba beans, all sharing a great sequence homology. The invention relates very preferably to the prohibin of Phaseolus lunatus whose common name is Lima bean. Phaseolus lunatus is widespread in Central America and South America. It is a bushy plant reaching 50 cm at maturity and producing pods from which beans are accommodated in various culinary preparations. The bean is rich in protein (21%), carbohydrates (63%) and mineral salts (2.4%) but contains very little lipid (0.6%). The prohibin is a protein synthesized by the plant probably as a stabilizing system of the seed awaiting germination or is used as defense against the attacks of insects which produce proteinases. The present invention therefore relates very specifically to a cosmetic composition comprising a plant protein inhibiting trypsin belonging to the class of Bowman-Birk inhibitors or a plant extract rich in this protein. Advantageously, the invention relates to a composition comprising an extract of legumes such as soybeans, peas, faba beans, or very preferably, of Phaseolus lunatus. It is a protein extract or an extract rich in protein having a trypsin inhibiting activity which can be obtained by extraction and isolation, or even more or less thorough purification, according to techniques

connues de l'homme du métier.known to those skilled in the art.

Il a été montré dans le cadre de la présente invention, que les activités enzymatiques de la trypsine et de la chymotrypsine diminuent de manière dose dépendante, l'inhibition étant totale à 0,01% et déjà significative à 0,0005%. Une composition cosmétique selon l'invention comprend donc de 0,05 à 10% et de préférence de 0,1 à 5% en poids de la composition totale de protéine végétale ou  It has been shown in the context of the present invention that the enzymatic activities of trypsin and chymotrypsin decrease in a dose-dependent manner, the inhibition being total at 0.01% and already significant at 0.0005%. A cosmetic composition according to the invention therefore comprises from 0.05 to 10% and preferably from 0.1 to 5% by weight of the total composition of vegetable protein or

d'extrait de plante riche en cette protéine.  plant extract rich in this protein.

La prohibine est une protéine d'environ 8000 daltons qui ne possède pas d'activité enzymatique directe, mas sa structure tridimensionnelle lui confère une conformation dans l'espace qui la rend affine pour les deux enzymes protéolytiques que sont la trypsine et la chymotrypsine. En conséquence, pour être active, la prohibine doit être avantageusement solubilisé dans un milieu lui permettant de conserver sa conformation. Or la solubilisation de la prohibine dans un milieu compatible avec une formulation cosmétique pose des difficultés que se propose précisément de résoudre la présente invention. En effet, la prohibine est un produit hydrosoluble peu compatible avec des tensio-actifs qui constituent un environnement défavorable par déformation de la structure  Prohibin is a protein of about 8000 daltons which does not have direct enzymatic activity, but its three-dimensional structure gives it a conformation in space which makes it affine for the two proteolytic enzymes which are trypsin and chymotrypsin. Consequently, to be active, the prohibin must be advantageously dissolved in a medium allowing it to maintain its conformation. However, the solubilization of prohibin in a medium compatible with a cosmetic formulation poses difficulties which the present invention specifically intends to solve. Indeed, prohibin is a water-soluble product which is hardly compatible with surfactants which constitute an unfavorable environment by deformation of the structure.

tertiaire et conduisent à une inactivation de la protéine.  tertiary and lead to inactivation of the protein.

L'invention se rapporte à cet effet tout préférentiellement à une composition cosmétique comprenant une phase aqueuse contenant une protéine végétale ou un extrait végétal présentant une activité inhibitrice de trypsine. Il peut alors s'agir d'une lotion, mais avantageusement, une composition cosmétique selon l'invention comprend deux phases distinctes, ladite phase aqueuse et une phase huileuse, qui sont mélangées par  The invention relates to this effect most preferably to a cosmetic composition comprising an aqueous phase containing a plant protein or a plant extract having a trypsin inhibiting activity. It may then be a lotion, but advantageously, a cosmetic composition according to the invention comprises two distinct phases, said aqueous phase and an oily phase, which are mixed by

agitation avant emploi.shaking before use.

La phase huileuse ou phase grasse permet de donner à la composition de l'invention davantage de " glisse " et de " richesse ". De préférence, le rapport pondérai entre la phase huileuse et la phase aqueuse est de l'ordre de 20/80. Une composition selon l'invention peut comprendre d'autres agents actifs, notamment des agents hydratants comme: - Un extrait d'algue, par exemple un extrait d'Himanthalia elongata, qui est une algue brune de la famille des fucales dont on extrait et purifie le contenu intracellulaire. Un tel extrait est riche en protéines, oligoéléements, mannitol et vitamines ce qui lui confère des propriétés hydratantes. Une composition selon l'invention peut comprendre de l'ordre de 0,1 à 5% d'un tel extrait. - Un extrait de Pinus Lambertiana ou de Pinus Sylvestris, qui est un pin de Nouvelle-Zélande, dont un extrait du tronc et des feuilles est très riche en cyclidol (D-pintol). Il s'agit d'un sucre constituant un oligosacharide majeur qui contribue à la survie de certaines espèces soumises à un stress salin. Ce sucre présente aussi des propriétés stabilisatrices des membranes qui confèrent à cet extrait des propriétés hydratantes au niveau cutané. Une composition selon l'invention peut  The oily phase or fatty phase makes it possible to give the composition of the invention more "glide" and "richness". Preferably, the weight ratio between the oily phase and the aqueous phase is of the order of 20/80. A composition according to the invention may comprise other active agents, in particular hydrating agents such as: - An alga extract, for example an extract of Himanthalia elongata, which is a brown alga from the fucales family from which one extracts and purifies the intracellular content. Such an extract is rich in proteins, trace elements, mannitol and vitamins which gives it moisturizing properties. A composition according to the invention can comprise of the order of 0.1 to 5% of such an extract. - An extract of Pinus Lambertiana or Pinus Sylvestris, which is a New Zealand pine, an extract of the trunk and leaves of which is very rich in cyclidol (D-pintol). It is a sugar constituting a major oligosaccharide which contributes to the survival of certain species subjected to saline stress. This sugar also has stabilizing properties on the membranes, which give this extract moisturizing properties on the skin. A composition according to the invention can

comprendre de l'ordre de 0,1 à 5% d'un tel extrait.  comprise of the order of 0.1 to 5% of such an extract.

- Un extrait de fleur de cactus, plus particulièrement de Cereus gandiflorus originaire des Antilles et d'Amérique Centrale. Il s'agit d'un extrait glycolique des fleurs de cactus qui renferme des composés phénoliques et des alcaloïdes adoucissants et hydratants pour la peau. Une composition selon l'invention peut  - An extract of cactus flower, more particularly of Cereus gandiflorus originating from the Antilles and Central America. It is a glycolic extract from cactus flowers that contains phenolic compounds and softening and moisturizing alkaloids for the skin. A composition according to the invention can

comprendre de l'ordre de 0,1 à 5% d'un tel extrait.  comprise of the order of 0.1 to 5% of such an extract.

- Un extrait de lupin blanc. Il s'agit d'un extrait protéique de lupinus albus riche en peptides glutaminés de faible poids moléculaire et en oligosaccharides. Il renforce la barrière cutanée par stimulation de la synthèse des lipides et protéines spécifiques de l'épiderme, limitant ainsi les pertes hydriques et donc permettant une meilleure hydratation du stratum corneum. Une composition selon l'invention peut  - An extract of white lupine. It is a protein extract of lupinus albus rich in low molecular weight glutamine peptides and in oligosaccharides. It strengthens the skin barrier by stimulating the synthesis of lipids and proteins specific to the epidermis, thus limiting water loss and therefore allowing better hydration of the stratum corneum. A composition according to the invention can

comprendre de l'ordre de 0,1 à 5% d'un tel extrait.  comprise of the order of 0.1 to 5% of such an extract.

D'autres avantages et caractéristiques de l'invention apparaîtront des exemples qui suivent concernant l'activité anti-trypsine et antichymotrypsine  Other advantages and characteristics of the invention will appear from the following examples concerning the anti-trypsin and antichymotrypsin activity

de la prohibine et de compositions selon l'invention.  prohibin and compositions according to the invention.

1) Activité anti-trypsine et anti-chymotrypsine  1) Anti-trypsin and anti-chymotrypsin activity

de la prohibine.prohibin.

La capacité d'inhibition de la trypsine et de  The ability to inhibit trypsin and

la chymotrypsine par la prohibine a été démontrée in vitro.  prohibin chymotrypsin has been demonstrated in vitro.

Deux esters d'amines substitués, la N-x-benzoyl-arginine  Two substituted amine esters, N-x-benzoyl-arginine

éthyl ester (BAE) pour la trypsine et la N-X-benzoyl-  ethyl ester (BAE) for trypsin and N-X-benzoyl-

tyrosine éthyl ester(BTEE) pour la chymotrypsine, ont été utilisés comme substrats spécifiques. Après hydrolyse de la fonction ester, l'apparition de l'amine-benzoyle libérée  tyrosine ethyl ester (BTEE) for chymotrypsin, were used as specific substrates. After hydrolysis of the ester function, the appearance of the released amine-benzoyl

est suivie par densité optique à 256 nm.  is followed by optical density at 256 nm.

La protéine a été testée à 6 concentrations différentes et les activités trypsine et chymotrypsine ont été évaluées par leur capacité à libérer l'amine spécifique. La figure 1 en annexe représente le pourcentage des vitesses d'hydrolyse en présence de concentrations croissantes de prohibine par rapport à la vitesse maximum  The protein was tested at 6 different concentrations and the trypsin and chymotrypsin activities were evaluated by their capacity to release the specific amine. Figure 1 in the appendix represents the percentage of hydrolysis rates in the presence of increasing concentrations of prohibin relative to the maximum rate

d'hydrolyse des enzymes sans prohibine.  hydrolysis of enzymes without prohibin.

Pour la chymotrypsine, qui est l'enzyme la plus fortement inhibée, la diminution d'activité mesurée par la vitesse d'hydrolyse du substrat aminé est donnée dans le  For chymotrypsin, which is the most strongly inhibited enzyme, the decrease in activity measured by the rate of hydrolysis of the amino substrate is given in the

tableau 1 ci-dessous.table 1 below.

Tableau 1 Protéine (prohibine) (%) Chymotrypsine (%)  Table 1 Protein (prohibin) (%) Chymotrypsin (%)

10-4 - 3810-4 - 38

1,2. 10-3 - 621.2. 10-3 - 62

2,5. 10-3 - 902.5. 10-3 - 90

10-3 - 9610-3 - 96

-2 - 100-2 - 100

2) Exemple d'un sérum hydratant biphase selon  2) Example of a two-phase hydrating serum according to

1' invention.1 invention.

Phase aqueuse Eau purifiée QSP 100,000 Polymère synthétique hydratant filmogène 10,000 Glycérine 10,000 PCANa 9,000 Dipropylène glycol 5,000 Prohibine 1,000 Himanthalia elongata 2,000 Extrait de fleurs de cactus 1, 000 Extrait de lupin blanc 1,000 Extrait de Pinus sylvestris 1,000 Triethanolamine 0,300 Chlorure de sodium 0,300 Gomme xanthane 0,200 Conservateurs 0,500 Agent séquestrant 0,100 Solution colorante 0,200 Phase Huileuse Perhydrosqualène 40,000 Isohexadecane 37,000 Ester d'acide gras 20,000 Parfum 1,800 Dérivé de vitamine E 1,000 Anti-oxydant 0,200  Aqueous phase Purified water QSP 100,000 Synthetic hydrating film-forming polymer 10,000 Glycerin 10,000 PCANa 9,000 Dipropylene glycol 5,000 Prohibin 1,000 Himanthalia elongata 2,000 Cactus flower extract 1,000 White lupine extract 1,000 Pinus sylvestris extract 1,000 Triethanolamine 0.300 Sodium chloride 0.300 Xanthan gum 0.200 Preservatives 0.500 Sequestering agent 0.100 Coloring solution 0.200 Oily phase Perhydrosqualene 40,000 Isohexadecane 37,000 Fatty acid ester 20,000 Perfume 1,800 Vitamin E derivative 1,000 Anti-oxidant 0.200

Claims (8)

REVENDICATIONS 1) Composition cosmétique pour la peau caractérisée en ce qu'elle comprend une protéine végétale ou un extrait végétal présentant une activité inhibitrice  1) Cosmetic composition for the skin, characterized in that it comprises a plant protein or a plant extract having an inhibitory activity de la trypsine.trypsin. 2) Composition cosmétique selon la revendication 1, caractérisée en ce qu'elle comprend une protéine végétale inhibant la trypsine appartenant à la classe des inhibiteurs de Bowman-Birk ou un extrait végétal  2) Cosmetic composition according to claim 1, characterized in that it comprises a plant protein inhibiting trypsin belonging to the class of Bowman-Birk inhibitors or a plant extract riche en cette protéine.rich in this protein. 3) Composition cosmétique selon l'une des  3) Cosmetic composition according to one of revendications 1 ou 2, caractérisée en ce qu'elle comprend  Claims 1 or 2, characterized in that it comprises une protéine ou un extrait de légumineuse comme le soja, le  a protein or legume extract such as soy, pois, la féverole, ou de Phaseolus lunatus.  pea, faba bean, or Phaseolus lunatus. 4) Composition cosmétique selon l'une des  4) Cosmetic composition according to one of revendications 1 à 3, caractérisée en ce qu'elle comprend  Claims 1 to 3, characterized in that it comprises une protéine de Phaseolus lunatus de poids moléculaire d'environ 8000 présentant une activité inhibitrice de la trypsine et de la chymotrypsine ou un extrait protéique de  a Phaseolus lunatus protein with a molecular weight of approximately 8000 having a trypsin and chymotrypsin inhibiting activity or a protein extract of Phaseolus lunatus contenant cette protéine.  Phaseolus lunatus containing this protein. ) Composition cosmétique selon l'une des  ) Cosmetic composition according to one of revendications 1 à 3, caractérisée en ce qu'elle comprend  Claims 1 to 3, characterized in that it comprises de 0,05 à 10% et de préférence de 0,1 à 5% en poids de la composition totale, d'une protéine végétale ou d'un extrait  from 0.05 to 10% and preferably from 0.1 to 5% by weight of the total composition, of a vegetable protein or of an extract végétal riche en cette protéine.vegetable rich in this protein. 6) Composition cosmétique selon l'une  6) Cosmetic composition according to one quelconque des revendications précédentes, caractérisée en  any of the preceding claims, characterized in ce qu'elle comprend une phase aqueuse contenant une protéine végétale ou un extrait végétale présentant une  what it comprises an aqueous phase containing a plant protein or a plant extract having a activité inhibitrice de trypsine.trypsin inhibiting activity. 7) Composition cosmétique selon l'une  7) Cosmetic composition according to one quelconque des revendications précédentes, caractérisée en  any of the preceding claims, characterized in ce qu'elle comprend deux phases distinctes, une phase aqueuse et une phase huileuse, ladite phase aqueuse contenant une protéine végétale ou un extrait végétale  that it comprises two distinct phases, an aqueous phase and an oily phase, said aqueous phase containing a vegetable protein or a plant extract présentant une activité inhibitrice de trypsine.  exhibiting trypsin inhibiting activity. 8) Composition cosmétique selon l'une  8) Cosmetic composition according to one quelconque des revendications précédentes, caractérisée en  any of the preceding claims, characterized in ce qu'elle comprend un ou plusieurs agents actifs choisis parmi: un extrait d'algue, par exemple un extrait d'Himanthalia elongata, un extrait de Pinus Lambertiana ou de Pinus Sylvestris, un extrait de fleur de cactus, un  what it includes one or more active agents chosen from: an algae extract, for example an extract of Himanthalia elongata, an extract of Pinus Lambertiana or Pinus Sylvestris, an extract of cactus flower, a extrait de lupin blanc.white lupine extract. 9) Utilisation d'un inhibiteur de trypsine végétal ou d'un extrait de plante contenant un tel inhibiteur comme agent actif dans la protection ou la  9) Use of a plant trypsin inhibitor or a plant extract containing such an inhibitor as an active agent in the protection or régénération du collagène de la peau.  regeneration of skin collagen. ) Procédé de traitement cosmétique du vieillissement ou de la déshydratation de la peau par application topique chez un sujet d'une quantité efficace d'un inhibiteur de trypsine végétal ou d'un extrait de  ) Method of cosmetic treatment of aging or dehydration of the skin by topical application to a subject of an effective amount of a plant trypsin inhibitor or an extract of plante contenant un tel inhibiteur.plant containing such an inhibitor.
FR0007156A 2000-06-05 2000-06-05 MOISTURIZING COSMETIC COMPOSITION COMPRISING A PLANT TRYPSIN INHIBITOR Expired - Fee Related FR2811226B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0007156A FR2811226B1 (en) 2000-06-05 2000-06-05 MOISTURIZING COSMETIC COMPOSITION COMPRISING A PLANT TRYPSIN INHIBITOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0007156A FR2811226B1 (en) 2000-06-05 2000-06-05 MOISTURIZING COSMETIC COMPOSITION COMPRISING A PLANT TRYPSIN INHIBITOR

Publications (2)

Publication Number Publication Date
FR2811226A1 true FR2811226A1 (en) 2002-01-11
FR2811226B1 FR2811226B1 (en) 2003-06-20

Family

ID=8850961

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0007156A Expired - Fee Related FR2811226B1 (en) 2000-06-05 2000-06-05 MOISTURIZING COSMETIC COMPOSITION COMPRISING A PLANT TRYPSIN INHIBITOR

Country Status (1)

Country Link
FR (1) FR2811226B1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1077063A3 (en) * 1999-07-27 2003-02-12 JOHNSON & JOHNSON CONSUMER COMPANIES, INC. Methods for treating skin pigmentation
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
WO2008080443A3 (en) * 2007-01-04 2009-03-26 Labo Cosprophar Ag Cosmetic composition for the treatment and/or prevention of skin stretch marks
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US20170020796A1 (en) * 2014-03-10 2017-01-26 Lucas Meyer Cosmetics Cosmetic uses of swertiamarin
US9920357B2 (en) 2012-06-06 2018-03-20 The Procter & Gamble Company Systems and methods for identifying cosmetic agents for hair/scalp care compositions
US10405795B1 (en) 2013-03-15 2019-09-10 The Procter & Gamble Company Methods of classifying periorbital dyschromia and systems therefor

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012135651A1 (en) 2011-03-31 2012-10-04 The Procter & Gamble Company Systems, models and methods for identifying and evaluating skin-active agents effective for treating dandruff/seborrheic dermatitis

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1939419A1 (en) * 1969-08-02 1971-02-18 Bayer Ag Use of biological protease inhibitors as deodorants
US4906457A (en) * 1988-09-06 1990-03-06 Washington State University Research Foundation, Inc. Compositions and methods for reducing the risk of sunlight and ultraviolet induced skin cancer
EP0473502A1 (en) * 1990-08-24 1992-03-04 Shiseido Company Limited Washing composition capable of preventing and ameliorating skin irritation
EP0532465A1 (en) * 1991-09-13 1993-03-17 Pentapharm A.G. Protein fraction for cosmetic and dermatological care of the skin
FR2774379A1 (en) * 1998-01-30 1999-08-06 Groupe Limagrain Holding PROCESS FOR THE PRODUCTION OF ALPHA 1-ANTITRYPSIN AND ITS VARIANTS BY PLANT CELLS, AND PRODUCTS CONTAINING THE ALPHA-ANTITRYPSIN OBTAINED THEREBY
WO2000059462A1 (en) * 1999-03-31 2000-10-12 Pentapharm Ag Composition for cosmetic and dermatological skin care

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1939419A1 (en) * 1969-08-02 1971-02-18 Bayer Ag Use of biological protease inhibitors as deodorants
US4906457A (en) * 1988-09-06 1990-03-06 Washington State University Research Foundation, Inc. Compositions and methods for reducing the risk of sunlight and ultraviolet induced skin cancer
EP0473502A1 (en) * 1990-08-24 1992-03-04 Shiseido Company Limited Washing composition capable of preventing and ameliorating skin irritation
EP0532465A1 (en) * 1991-09-13 1993-03-17 Pentapharm A.G. Protein fraction for cosmetic and dermatological care of the skin
FR2774379A1 (en) * 1998-01-30 1999-08-06 Groupe Limagrain Holding PROCESS FOR THE PRODUCTION OF ALPHA 1-ANTITRYPSIN AND ITS VARIANTS BY PLANT CELLS, AND PRODUCTS CONTAINING THE ALPHA-ANTITRYPSIN OBTAINED THEREBY
WO2000059462A1 (en) * 1999-03-31 2000-10-12 Pentapharm Ag Composition for cosmetic and dermatological skin care

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
EP1077063A3 (en) * 1999-07-27 2003-02-12 JOHNSON & JOHNSON CONSUMER COMPANIES, INC. Methods for treating skin pigmentation
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US7897144B2 (en) 2001-02-28 2011-03-01 Johnson & Johnson Comsumer Companies, Inc. Compositions containing legume products
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
WO2008080443A3 (en) * 2007-01-04 2009-03-26 Labo Cosprophar Ag Cosmetic composition for the treatment and/or prevention of skin stretch marks
US9920357B2 (en) 2012-06-06 2018-03-20 The Procter & Gamble Company Systems and methods for identifying cosmetic agents for hair/scalp care compositions
US10405795B1 (en) 2013-03-15 2019-09-10 The Procter & Gamble Company Methods of classifying periorbital dyschromia and systems therefor
US20170020796A1 (en) * 2014-03-10 2017-01-26 Lucas Meyer Cosmetics Cosmetic uses of swertiamarin
US11285093B2 (en) * 2014-03-10 2022-03-29 International Flavors & Fragrances Inc. Cosmetic uses of swertiamarin

Also Published As

Publication number Publication date
FR2811226B1 (en) 2003-06-20

Similar Documents

Publication Publication Date Title
EP2515840B1 (en) Cosmetic and/or pharmaceutical composition comprising an extract of carob as active agent for activating aquaporin expression
JP2012524049A (en) Cosmetic and / or pharmaceutical composition comprising a peptide hydrolyzate capable of enhancing the barrier function
FR2811226A1 (en) Cosmetic composition for treatment of aging or dehydrated skin contains vegetable protein having trypsin inhibiting activity or vegetable extract rich in such protein
EP2421884B1 (en) Peptide hydrolysate proteasome activators and compositions containing same
EP3377623A1 (en) Process for obtaining an aqueous extract enriched with small rnas from a plant material and extracts resulting from the process
EP0809484B1 (en) Cosmetic or pharmaceutical, particularly dermatological, composition containing a bertholletia extract
EP2414381B1 (en) Anti aging peptides which acitivate the proteasome, and compostions comprising them
EP2588075B1 (en) Use of a peptidic extract of pea as and antioxidant in a cosmetic composition
EP0283349B1 (en) Process for obtaining tannic principles of vegetable origin, cosmetologic and pharmaceutical composition containing the tannic principle obtained by the process
CN102459309B (en) Bleaching peptide hydrolysate proteasome activator and compositions containing same
EP2413891B1 (en) Anti aging peptides which acitivate the proteasome, and compostions comprising them
EP0652763B1 (en) Raw extracts of blue algae, method of preparation and applications in cosmetology and dermatology
EP2419439B1 (en) Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolysate
FR2840809A1 (en) Use of a hydrophilic fraction of sea-buckthorn fruit for preparing a cosmetic, dermatological or pharmaceutical composition for treatment of the dermis
FR2971711A1 (en) Use of extract of Einkorn wheat (Triticum monococcum), as active agent for activating synthesis of extracellular matrix protein of skin, in cosmetic composition comprising medium for fighting against the appearance of signs of skin aging
WO2007003771A2 (en) Use of a yeast extract in the form of an active agent for inducing a synthesis of sirt proteins in skin cells
FR2973381A1 (en) New oligosaccharide compounds useful e.g. for maintaining the integrity of the constituent molecules in the extracellular matrix and for reducing the glycation and/or hyperkeratinization process
FR3134515A1 (en) Crocus sativus flower extracts, compositions comprising them and their uses in oral care
WO2014029948A2 (en) Flax extract and cosmetic composition comprising said extract for increasing the level of intracellular coenzyme q10
EP0651751B1 (en) Family of porphin ring substances, method of obtaining them from cyanophyceae, and applications as cosmetics and as therapeutic products
KR102890624B1 (en) Astilboides tabularis extract or ethyl acetate fraction of astilboides tabularis extract with excellent anti-aging effects on skin and cosmetic composition comprising the same
WO2007003773A2 (en) Use of a yeast extract in the form of an active agent for inducing a synthesis of sirt proteins in skin cells
FR2944795A1 (en) New peptide hydrolyzates, enriched in bioactive peptide having arginine residue, lysine residue and glycine residue, are proteasome activators, useful e.g. to treat or prevent sign of skin aging (e.g. wrinkles) and photoaging
FR2761264A1 (en) USE OF BAMBARA PEA SEED EXTRACT (S) IN A COSMETIC COMPOSITION AND CORRESPONDING COSMETIC COMPOSITION
FR2849776A1 (en) Cosmetic, dermatological and/or pharmaceutical compositions containing aqueous extracts of Curcubita genus plant seeds, useful e.g. for combating skin aging symptoms and/or inflammation

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20100226